title: Biomarkers, assays, and therapies for Alzheimer disease.
authors.affiliation: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; dan.beriault@mail.utoronto.ca.
authors.forename: Daniel R
authors.initials: DR
authors.lastname: Beriault
authors.affiliation: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada;
authors.forename: Eleftherios P
authors.initials: EP
authors.lastname: Diamandis
authors.affiliation: Associate Professor in Neurochemistry, Department of Neuroscience and Physiology, University of Gothenburg, Sweden;
authors.forename: Erik
authors.initials: E
authors.lastname: Portelius
authors.affiliation: Clinical Biochemist, Head of Neurochemistry Unit, Department of Biochemistry and Molecular Biology, Hospices Civils de Lyon, France.
authors.forename: Armand
authors.initials: A
authors.lastname: Perret-Liaudet
authors.affiliation: Director of Neurology and the Memory and Aging Program, Butler Hospital, and Professor of Neurology and Psychiatry, the Warren Alpert Medical School of Brown University, Providence, RI.
authors.forename: Stephen
authors.initials: S
authors.lastname: Salloway
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid; D000818:Animals; D015415:Biomarkers / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid; D019963:Clinical Chemistry Tests / Q000379:methods*; D002986:Clinical Trials as Topic; D004797:Enzyme-Linked Immunosorbent Assay; D005104:Expert Testimony; D006801:Humans; D008279:Magnetic Resonance Imaging; D008822:Mice, Transgenic; D049268:Positron-Emission Tomography; D016875:tau Proteins / Q000134:cerebrospinal fluid
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers; C054369:MAPT protein, human; D016875:tau Proteins